Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhaled Medications01:23

Inhaled Medications

601
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
601

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

New Approach Methodologies (NAMs) for Carcinogenicity Evaluation.

Toxicologic pathology·2026
Same journal

2025 International Academy of Toxicologic Pathology (IATP) Satellite Symposium: Pathology Working Groups (PWGs) in Toxicologic Pathology.

Toxicologic pathology·2026
Same journal

New Modalities and Carcinogenicity Assessment.

Toxicologic pathology·2026
Same journal

Hemangiosarcomas in Intercostal Brown Adipose Tissues of the Sternum Induced by Urethane in TgrasH2 Mice.

Toxicologic pathology·2026
Same journal

Adeno-Associated Virus Gene Therapy: Is There a Risk of Insertional Mutagenesis?

Toxicologic pathology·2026
Same journal

Imatinib-Induced Hemorrhage in the Corpus Luteum Is Attenuated in Pseudopregnant and Hypophysectomized Rats.

Toxicologic pathology·2026
See all related articles

Related Experiment Video

Updated: Dec 10, 2025

Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models
07:56

Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models

Published on: November 11, 2020

4.6K

Perspectives on Lung Dose and Inhaled Biomolecules.

Ronald K Wolff1

  • 1RK Wolff Safety Consulting Inc, Fort Myers, FL, USA.

Toxicologic Pathology
|August 28, 2020
PubMed
Summary
This summary is machine-generated.

Understanding inhaled dose is crucial for human safety and toxicology studies. For biologics, the alveolar region dose is most critical, not total inhaled dose.

Keywords:
biotherapeuticsinhalation toxicologylung depositionmonoclonal antibodiespeptidespulmonary dosimetry

More Related Videos

Direct Intrabronchial Administration to Improve the Selective Agent Deposition Within the Mouse Lung
07:10

Direct Intrabronchial Administration to Improve the Selective Agent Deposition Within the Mouse Lung

Published on: May 20, 2019

14.3K
Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

41.2K

Related Experiment Videos

Last Updated: Dec 10, 2025

Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models
07:56

Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models

Published on: November 11, 2020

4.6K
Direct Intrabronchial Administration to Improve the Selective Agent Deposition Within the Mouse Lung
07:10

Direct Intrabronchial Administration to Improve the Selective Agent Deposition Within the Mouse Lung

Published on: May 20, 2019

14.3K
Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

41.2K

Area of Science:

  • Pharmacology
  • Toxicology
  • Respiratory Medicine

Background:

  • Dose is critical for inhaled agents, impacting human safety and toxicology studies.
  • Unlike other administration routes, inhaled dose determination and its direct toxicity correlation are complex.
  • Understanding dose distribution within the respiratory tract is essential for accurate risk assessment.

Purpose of the Study:

  • To review dose distribution in the respiratory tract following inhalation exposure.
  • To examine the implications of regional deposition for biologics of varying molecular weights.
  • To identify the most relevant dose metric for assessing biologic toxicity after inhalation.

Main Methods:

  • Literature review of dose determination in inhalation studies.
  • Analysis of regional deposition patterns for inhaled agents.
  • Case examples illustrating biologic deposition and absorption characteristics.

Main Results:

  • Total inhaled dose is not always the best indicator of toxicity for inhaled agents.
  • Regional deposition significantly influences the toxicological impact of inhaled substances.
  • Biologics, due to their size, show low absorption from ciliated epithelia, making alveolar deposition the key factor.

Conclusions:

  • Accurate dose assessment in inhalation studies requires understanding regional deposition.
  • For biologics, the dose deposited in the alveolar region is of primary toxicological interest.
  • Focusing on alveolar deposition aids in interpreting safety data and comparing human and animal studies.